Abich Financial Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

Abich Financial Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$84.9K	Buy	+10,779	New	+$76.7K	0.03%	255

Other funds holding FOLD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Abich Financial Wealth Management's FOLD Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Amicus Therapeutics (FOLD) in Q3 2025: 10,779 shares worth $84.9K. The stake represents 0.03% of the portfolio and ranks #255 among its holdings.

287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

Abich Financial Wealth Management held 10,779 shares of Amicus Therapeutics worth $84.9K as of Q3 2025.
Amicus Therapeutics was a new Abich Financial Wealth Management position in Q3 2025.
Amicus Therapeutics made up 0.03% of Abich Financial Wealth Management's portfolio in Q3 2025, its #255 holding.
287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.